SANAR BIOTECH CORP.
© Copyright –SANAR BIOTECH CORP.
| Product Name | Application | Status | Modality |
|---|---|---|---|
| BB-101 | Androgenic Alopecia | Pre-Phase II | Topical Administration |
| Product Name: | BB-101 |
|---|---|
| Application： | Androgenic Alopecia |
| Status： | Pre-Phase II |
| Modality： | Topical Administration |
更多關於BB-101
BB-101 enhances cell growth/survival signaling pathways and promotes angiogenesis. It upregulates mTORC2-related gene expression in human dermal fibroblasts, while also boosting the expression of genes associated with cell proliferation, angiogenesis, and cell survival. In addition, BB-101 increases VEGF and beta-catenin protein expression in human dermal papilla cells, thereby improving hair follicle viability and alleviating symptoms of androgenetic alopecia.
| Age Ancla | Anti-Hair Loss | Phase I | Medical Device (Certified) |
| Product Name: | Age Ancla |
|---|---|
| Application： | Anti-Hair Loss |
| Status： | Phase I |
| Modality： | Medical Device (Certified) |
更多關於Age Ancla
Age Ancla為BB-101結合微針之創新技術，微針貼片採用可分解透明質酸微晶結構，能穩定且高效地將BB-101直接釋放至真皮層。使用時只需將貼片貼於頭皮表面，操作更加簡便，提供更有效的解決方案來改善患者的生髮效果。
| SB-01 | Anti-Aging | INCI Registered | Cosmetic Ingredient |
| Product Name: | Age Ancla |
|---|---|
| Application： | Anti-Hair Loss |
| Status： | Phase I |
| Modality： | Medical Device (Certified) |
更多關於Age Ancla
Age Ancla為BB-101結合微針之創新技術，微針貼片採用可分解透明質酸微晶結構，能穩定且高效地將BB-101直接釋放至真皮層。使用時只需將貼片貼於頭皮表面，操作更加簡便，提供更有效的解決方案來改善患者的生髮效果。